An Open-label RCT to Evaluate a New Treatment Regimen for Patients With Multi-drug Resistant Tuberculosis

NCT02454205 · clinicaltrials.gov ↗

PHASE2,PHASE3

Phase

COMPLETED

Status

154

Enrollment

OTHER

Sponsor class

Conditions

Tuberculosis
Multidrug Resistant Tuberculosis
Extensively-drug Resistant Tuberculosis

Interventions

DRUG: Linezolid
DRUG: Bedaquiline
DRUG: Levofloxacin
DRUG: Pyrazinamide
DRUG: Isoniazid
DRUG: Ethionamide
DRUG: Terizidone
DRUG: Moxifloxacin
DRUG: Kanamycin

Sponsor

University of Cape Town

Collaborators

[object Object]
[object Object]
[object Object]
[object Object]